These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 18715612)
1. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612 [TBL] [Abstract][Full Text] [Related]
2. Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm. Zhang L; Lohse CM; Dao LN; Smyrk TC Hum Pathol; 2011 Mar; 42(3):324-31. PubMed ID: 21190722 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours. La Rosa S; Rigoli E; Uccella S; Novario R; Capella C Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496 [TBL] [Abstract][Full Text] [Related]
4. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106 [TBL] [Abstract][Full Text] [Related]
5. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates? Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481 [TBL] [Abstract][Full Text] [Related]
7. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671 [TBL] [Abstract][Full Text] [Related]
8. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma. Buishand FO; Kik M; Kirpensteijn J Vet J; 2010 Jul; 185(1):62-7. PubMed ID: 20570189 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Ekeblad S; Skogseid B; Dunder K; Oberg K; Eriksson B Clin Cancer Res; 2008 Dec; 14(23):7798-803. PubMed ID: 19047107 [TBL] [Abstract][Full Text] [Related]
12. [Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors]. Terris B Ann Pathol; 2002 Oct; 22(5):367-74. PubMed ID: 12483154 [TBL] [Abstract][Full Text] [Related]
14. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression. Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862 [TBL] [Abstract][Full Text] [Related]
15. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? Ferrone CR; Tang LH; Tomlinson J; Gonen M; Hochwald SN; Brennan MF; Klimstra DS; Allen PJ J Clin Oncol; 2007 Dec; 25(35):5609-15. PubMed ID: 18065733 [TBL] [Abstract][Full Text] [Related]